Axiom Investors LLC Biogen Inc. Transaction History

Axiom Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $12.1 Million - $18.9 Million	-55,672 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $21,426 - $28,019	-73 Reduced 0.13%	55,672 $19.7 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $7.6 Million - $9.06 Million	-29,515 Reduced 34.62%	55,745 $16.2 Million
Q1 2018 May 14, 2018	SELL	$260.13 - $367.91 $44,222 - $62,544	-170 Reduced 0.2%	85,260 $23.3 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $26.3 Million - $29.4 Million	85,430	85,430 $27.2 Million

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.